samedan logo
 
 
spacer
home > pmps > winter 2020 > a combination of problems
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

A Combination of Problems




Products combining multiple active pharmaceutical ingredients (APIs) offer drug companies the opportunity to create effective treatments that are more in line with demand for patient-centric medications. However, developing these products is a highly complex process when compared to the development of medicines that contain a single API. Combining two or more active ingredients in a formulation in a way that ensures each is delivered as desired requires specialist development and production capabilities, often in addition to specifically designed excipient technologies. Adding to the challenges are the more complex regulatory requirements that are necessary for these types of products.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the author


Lei Mao is the Director of Inhalation Science and Product Development at Recipharm Laboratories. With over 20 years of experience, Lei has a wealth of knowledge in formulation and inhalation product development within the pharma industry. He started a career working as a Senior Scientist, where he developed particulate formulations for inhalation applications, and has since held managerial positions for Big Pharma companies. Lei also holds a PhD in Pharmaceutical Sciences and a degree in Pharmacy.
Print this page
Send to a friend
Privacy statement
News and Press Releases

PM Group Worldwide Ltd and The Datateam Media Group announce acquisition of Samedan Ltd

PMGroup Worldwide Ltd and The Datateam Media Group are pleased and excited to announce the acquisition of pharmaceutical publishers Samedan Ltd. The deal brings together three publishing powerhouses in the pharmaceutical and healthcare sector - with Samedan joining PMGroup and PharmaTimes Media Ltd as part of The Datateam Media Groupís healthcare division.
More info >>

White Papers

Advantages of Quantitative NMR for the Determination of Relative Response Factors

Novatia, LLC

Quantitative NMR (qNMR) is a technique that is being applied broadly and at an increasing rate in the field of pharmaceutical analysis (1). This white paper highlights the advantages of using qNMR to determine Relative Response Factors (RRFs) for pharmaceutical impurities detectable by HPLC. A single determination of RRFs using qNMR allows for simple and accurate quantitation of impurities which eliminates the need for preparation, qualification, and storage of reference standards. An example is presented here, which demonstrates quantitation of known impurities that have variable responses to UV-VIS detection, thereby providing a more accurate assessment of impurity levels than UV-VIS response alone.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement